Cue Biopharma Inc reports results for the quarter ended in December - Earnings Summary

Cue Biopharma

16/03/2022 23:00

* Cue Biopharma Inc  CUE.OQ  reported a quarterly adjusted
loss
of 25 cents​​ per share for the quarter ended in December. The
mean expectation of six analysts for the quarter was for a loss
of 38 cents per share.
    * Revenue rose 1,636.5% to $8.25 million from a year ago; 
analysts expected $2.97 million. 
    * Cue Biopharma Inc's reported EPS for the quarter was a
loss
of 25 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cue Biopharma Inc shares had fallen by 61.0% this quarter.
    * The company reported a quarterly loss of $8.38 million.
    * Wall Street's median 12-month price target for Cue
Biopharma Inc
is $30.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 16 at 11:00 p.m.  ​All
figures in US dollars unless otherwise stated